- Home
- PMAX vs ADXN Comparison
PMAX vs ADXN Comparison
Compare PMAX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- ADXN
- Stock Information
- Founded
- PMAX 2019
- ADXN 2002
- Country
- PMAX Hong Kong
- ADXN Switzerland
- Employees
- PMAX N/A
- ADXN N/A
- Industry
- PMAX
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- PMAX
- ADXN Health Care
- Exchange
- PMAX Nasdaq
- ADXN Nasdaq
- Market Cap
- PMAX 4.7M
- ADXN 7.5M
- IPO Year
- PMAX 2024
- ADXN N/A
- Fundamental
- Price
- PMAX $0.39
- ADXN $8.16
- Analyst Decision
- PMAX
- ADXN Strong Buy
- Analyst Count
- PMAX 0
- ADXN 1
- Target Price
- PMAX N/A
- ADXN $30.00
- AVG Volume (30 Days)
- PMAX 3.4M
- ADXN 8.4K
- Earning Date
- PMAX 05-06-2025
- ADXN 06-05-2025
- Dividend Yield
- PMAX N/A
- ADXN N/A
- EPS Growth
- PMAX N/A
- ADXN N/A
- EPS
- PMAX 0.04
- ADXN 0.06
- Revenue
- PMAX $5,970,263.00
- ADXN $701,260.00
- Revenue This Year
- PMAX N/A
- ADXN N/A
- Revenue Next Year
- PMAX N/A
- ADXN N/A
- P/E Ratio
- PMAX $9.14
- ADXN $1.06
- Revenue Growth
- PMAX 30.05
- ADXN N/A
- 52 Week Low
- PMAX $0.28
- ADXN $6.51
- 52 Week High
- PMAX $4.70
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- PMAX N/A
- ADXN 58.71
- Support Level
- PMAX N/A
- ADXN $6.75
- Resistance Level
- PMAX N/A
- ADXN $8.20
- Average True Range (ATR)
- PMAX 0.00
- ADXN 0.42
- MACD
- PMAX 0.00
- ADXN 0.11
- Stochastic Oscillator
- PMAX 0.00
- ADXN 97.63
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.